News | February 25, 2022
Canada approves plant-based Covid-19 vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
New biotechnology product aims to be world's fastest automatic sanitary solution
he financing was significantly oversubscribed with high demand from both existing and new investors.
Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
The sale is expected to close in the first quarter of 2022
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
